The NULISA™ platform combines a proprietary sequential immunocomplex capture and release mechanism with next-generation sequencing (NGS) advances to enable ultra-high sensitivity, scalable analysis of critical cytokine and chemokine biomarkers in human samples. We offer analytical services for:
"*" indicates required fields
Not only are we a Certified Service Provider for Alamar Biosciences’ NULISAseq panels — we can also integrate these protein measures with metabolomics and lipidomics data derived from the same samples using our rLC-MS platform. Findings can also be validated in our Human Biology Database comprised of data from 100,000+ biosamples.
Gain a more holistic view of the molecular mechanisms of inflammation and disease with multi-omics data generation, analysis, and biomarker cross-validation.